Spruce Biosciences Inc reports results for the quarter ended in June - Earnings Summary

Spruce Biosciences

10/08/2021 23:03

* Spruce Biosciences Inc  SPRB.OQ  reported a quarterly adjusted
loss of 50 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 45 cents per share.
* Reported revenue was zero​;  analysts expected zero. 
* Spruce Biosciences Inc's reported EPS for the quarter was a
loss of 50 cents​.
* The mean earnings estimate of analysts had risen by about 4.3%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Spruce Biosciences Inc shares had fallen by 27.8% this
quarter and lost 66.7% so far this year.
* The company reported a quarterly loss of $11.8 million.
* Wall Street's median 12-month price target for Spruce
Biosciences Inc is $30.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 10 at 10:03 p.m.  ​All
figures in US dollars unless otherwise stated